ADIPOQ and insulin-resistant diabetes mellitus: Significantly, the genetic mutation of the adiponectin gene, which causes low plasma adiponectin levels, is associated with the metabolic syndrome, including insulin-resistant diabetes and atherosclerotic disease[9].